A Preclinical Consortium Approach for Assessing the Efficacy of Combined Anti-CD3 Plus IL-1 Blockade in Reversing New-Onset Autoimmune Diabetes in NOD Mice. (Record no. 25588507)

MARC details
000 -LEADER
fixed length control field 02419 a2200673 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517072123.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201706s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1939-327X
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.2337/db15-0492
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Gill, Ronald G
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20170606
245 00 - TITLE STATEMENT
Title A Preclinical Consortium Approach for Assessing the Efficacy of Combined Anti-CD3 Plus IL-1 Blockade in Reversing New-Onset Autoimmune Diabetes in NOD Mice.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Diabetes
Date of publication, distribution, etc. 05 2016
300 ## - PHYSICAL DESCRIPTION
Extent 1310-6 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Comparative Study; Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Animals
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Autoimmune Diseases
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Biomedical Research
General subdivision methods
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element CD3 Complex
General subdivision chemistry
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Diabetes Mellitus, Type 1
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Administration Schedule
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Therapy, Combination
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Immunoglobulin Fab Fragments
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Immunotherapy
General subdivision methods
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Insulin
General subdivision metabolism
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Insulin Secretion
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Insulin-Secreting Cells
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Interleukin-1 Receptor Accessory Protein
General subdivision antagonists & inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Interleukin-1beta
General subdivision antagonists & inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Mice, Inbred NOD
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Multicenter Studies as Topic
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pilot Projects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Receptors, Interleukin-1 Type I
General subdivision antagonists & inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Recombinant Fusion Proteins
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Reproducibility of Results
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Research Design
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Specific Pathogen-Free Organisms
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element United States
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Pagni, Philippe P
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kupfer, Tinalyn
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Wasserfall, Clive H
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Deng, Songyan
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Posgai, Amanda
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Manenkova, Yulia
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bel Hani, Amira
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Straub, Laura
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bernstein, Philip
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Atkinson, Mark A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Herold, Kevan C
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name von Herrath, Matthias
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Staeva, Teodora
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ehlers, Mario R
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Nepom, Gerald T
773 0# - HOST ITEM ENTRY
Title Diabetes
Related parts vol. 65
-- no. 5
-- p. 1310-6
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.2337/db15-0492">https://doi.org/10.2337/db15-0492</a>
Public note Available from publisher's website

No items available.